Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nature's Health receives warning

This article was originally published in The Tan Sheet

Executive Summary

FDA warns Nature's Health Co. that at least 18 of its products marketed as supplements are unapproved drugs due to unlawful disease treatment and prevention claims that "were too numerous to list." It also warns the Salt Lake City firm that several of the products, including Cardiac Balance I to control arrhythmia and Flavescent for autoimmune system disease symptom relief, are misbranded because they are offered for conditions that are not self-diagnosable or self-treatable. According to the Sept. 21 letter, the products advertised at 1www.nature-s-health.com were not recognized as safe and effective and, therefore, are new drugs

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104609

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel